We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Distribution Agreement for Brachytherapy

By MedImaging staff writers
Posted on 15 Aug 2005
Oncura (Philadelphia, PA, USA), a leader in the minimally invasive management of prostate cancer, has announced a worldwide agreement to distribute North American Scientific's (Chatsworth, CA, USA) palladium-103 prostate brachytherapy seeds, called Prospera.

The agreement, which starts on September 9, 2005, runs for five years, and allows Oncura to provide its customers with an uninterrupted supply of palladium-103 seeds. More...
The seed will be available in the full range of presentation options required by today's brachytherapy programs.

"Oncura has entered into this partnership to ensure that we fully satisfy the needs of all prostate brachytherapy customers,” stated James McGlone, president and CEO, Oncura. "We've increased our long-term commitment to the brachytherapy community and look forward to the opportunity of providing an enhanced level of service; this agreement will allow us to do so.”

The seeds have been supported by dosimetry studies recommended by the American Association of Physicists in Medicine (AAPM). Oncura will provide Prospera as a standard loose seed in their novel Strand, as well as in preloaded needles or Mick cartridges. Added to its range of iodine-125 products, Rapid Strand, OncoSeed, and EchoSeed, the introduction of Prospera will provide increased flexibility and convenience for all prostate brachytherapy programs.





Related Links:
Oncura
North American Scientifics'

Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.